ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,206,000 | -49.9% | 82,549 | -63.5% | 0.02% | -50.0% |
| Q2 2021 | $28,361,000 | -16.2% | 226,005 | -9.5% | 0.04% | -21.4% |
| Q1 2021 | $33,863,000 | -7.0% | 249,705 | -12.2% | 0.06% | -13.8% |
| Q4 2020 | $36,395,000 | +13.5% | 284,475 | -0.1% | 0.06% | +3.2% |
| Q3 2020 | $32,059,000 | +37.4% | 284,893 | +16.3% | 0.06% | +26.0% |
| Q2 2020 | $23,331,000 | +59.5% | 244,893 | +50.5% | 0.05% | +31.6% |
| Q1 2020 | $14,626,000 | +197.9% | 162,747 | +75.8% | 0.04% | +280.0% |
| Q4 2019 | $4,909,000 | +77.2% | 92,575 | +32.1% | 0.01% | +66.7% |
| Q3 2019 | $2,770,000 | -3.6% | 70,104 | +0.2% | 0.01% | 0.0% |
| Q2 2019 | $2,873,000 | -11.8% | 69,947 | 0.0% | 0.01% | -25.0% |
| Q1 2019 | $3,257,000 | +7.0% | 69,947 | +0.1% | 0.01% | 0.0% |
| Q4 2018 | $3,044,000 | -18.2% | 69,880 | +7.5% | 0.01% | 0.0% |
| Q3 2018 | $3,719,000 | +47.9% | 64,984 | +25.4% | 0.01% | +166.7% |
| Q2 2018 | $2,514,000 | +124.9% | 51,808 | +81.2% | 0.00% | 0.0% |
| Q1 2018 | $1,118,000 | -53.6% | 28,588 | -49.7% | 0.00% | 0.0% |
| Q4 2017 | $2,410,000 | +51.6% | 56,792 | +33.2% | 0.00% | -25.0% |
| Q3 2017 | $1,590,000 | +74.3% | 42,628 | +42.0% | 0.00% | +100.0% |
| Q2 2017 | $912,000 | -74.8% | 30,014 | -78.1% | 0.00% | -77.8% |
| Q1 2017 | $3,621,000 | +2.6% | 136,800 | -1.1% | 0.01% | 0.0% |
| Q4 2016 | $3,530,000 | -29.9% | 138,305 | -0.5% | 0.01% | -25.0% |
| Q3 2016 | $5,033,000 | +18.5% | 139,053 | +11.2% | 0.01% | +20.0% |
| Q2 2016 | $4,248,000 | +28.8% | 125,000 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $3,299,000 | -45.9% | 125,000 | 0.0% | 0.01% | -42.9% |
| Q4 2015 | $6,095,000 | +95.1% | 125,000 | -0.4% | 0.01% | +100.0% |
| Q3 2015 | $3,124,000 | -21.3% | 125,472 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $3,970,000 | – | 125,472 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 3,133,234 | $124,076,000 | 82.43% |
| Deer VII & Co. Ltd. | 1,105,964 | $39,417,000 | 9.51% |
| Foresite Capital Management I, LLC | 66,000 | $2,614,000 | 2.54% |
| QVT Financial LP | 556,574 | $21,592,000 | 1.27% |
| Orbimed Advisors | 2,117,648 | $83,859,000 | 1.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $1,980,000 | 0.55% |
| WALL STREET ASSOCIATES | 93,800 | $3,714,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 197,219 | $7,810,000 | 0.28% |
| EAM Investors, LLC | 37,871 | $1,500,000 | 0.27% |
| Granite Point Capital Management, L.P. | 30,000 | $1,188,000 | 0.20% |